Information for patients

Working with you through your CAR T cell therapy

Our development programs, including clinical trials, focus on developing safe and efficacious therapies for patients.

Our Clinical Trials

Clinical trials are required to gain regulatory approval for new medicines to advance patient care.
A list of clinical trials supported by Autolus, and our collaborators is below and all further information can be found on ClinicalTrials.gov.

Program

Phase

Indication

Study Name

Further Information

Obe-cel

2

Adult ALL

FELIX

NCT04404660

Obe-cel

1

B-NHL

ALLCAR19

NCT02935257

Obe-cel

1

PCNSL

CAROUSEL

NCT04443829

AUTO1/22

1

Pediatric ALL

CARPALL

NCT02443831

AUTO4

1/2

PTCL

LIBRAT1

NCT03590574

AUTO8

1

Multiple Myeloma

MCARTY

NCT04795882

Contact us for information about Autolus' clinical trials on [email protected]

Helping patients and carers through their CAR T therapy journey

In partnership with the Northern Alliance Advanced Therapy Treatment Centre (NA-ATTC) consortium, we have launched a comprehensive guide to help patients and carers through their CAR T therapy journey.

The Guide is intended for people who are either considering enrolling in or are already enrolled in a CAR T cell therapy clinical trial. It has been developed to be agnostic to an individual trial or CAR T product. Patients and caregivers are provided with support via education and advice throughout the whole treatment journey whilst also providing a teaching aid for clinical staff managing CAR T clinical trials.

Within the guide you will find:

  • General information about CAR T cell therapy clinical trials
  • An explanation of how CAR T cell therapy works
  • What can be expected during each step of the process
  • Information about side effects
  • Information specifically for carers
  • Guidance on how and where to find support

Additional information

For patients located in the US:

You can get support from the Leukemia & Lymphoma Society who will assist you throughout the entire clinical-trial process. To access these services:

  • Email: [email protected]
  • Call: (800) 955-4572
    Monday to Friday, 9 a.m. to 9 p.m. eastern time
  • Leave a message 24/7 and you will receive a call back. You can call anytime and leave a message and you will receive a call back within one working day. You can also listen to recorded information about LLS’ programs.
  • Website: www.lls.org 

For patients located in the UK:

Blood Cancer UK through their Clinical Trials Support Service are available to support you and help you navigate through the entire clinical trial process. To access these services:

  • Email: [email protected]
  • Call: 0808 2080 888 
  • Monday to Friday, 10 a.m. to 7 p.m. and Saturday to Sunday, 10 a.m. to 1 p.m.
  • Leave a message 24/7 and you will receive a call back. You can call anytime and leave a message and you will receive a call back within one working day.
  • Website: www.bloodcancer.org.uk